X-18642012-A-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.667T>C(p.Cys223Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C223W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000330.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RS1 | NM_000330.4 | MANE Select | c.667T>C | p.Cys223Arg | missense | Exon 6 of 6 | NP_000321.1 | ||
| CDKL5 | NM_001037343.2 | c.2714-3995A>G | intron | N/A | NP_001032420.1 | ||||
| CDKL5 | NM_003159.3 | c.2714-3995A>G | intron | N/A | NP_003150.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RS1 | ENST00000379984.4 | TSL:1 MANE Select | c.667T>C | p.Cys223Arg | missense | Exon 6 of 6 | ENSP00000369320.3 | ||
| RS1 | ENST00000476595.1 | TSL:1 | n.1158T>C | non_coding_transcript_exon | Exon 5 of 5 | ||||
| CDKL5 | ENST00000379989.6 | TSL:1 | c.2714-3995A>G | intron | N/A | ENSP00000369325.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Juvenile retinoschisis Pathogenic:3
REVEL score is 0.974 (PP3_str). Variant is located in a mutational hotspot where >50% of variants are pathogenic (PM1). Variant is not found in gnomAD exomes and genomes (PM2). Other variants on this amino acid residue have been classified as pathogenic (PM5, p.Cys223Gly; pCys223Tyr). RS1 variants are specific to retinoschisis phenotypes (PP4). Experimental studies have shown that this variant affects RS1 protein function (PMID: 16361673).
NM_000330.4(RS1):c.667T>C (p.Cys223Arg) is a missense variant encoding the substitution of cysteine with arginine at amino acid 223. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). This variant has been reported in at least 3 apparently unrelated probands meeting the PS4 requirements of a male diagnosed with X-linked retinoschisis (PMID: 34645606, PMID: 10533068, PMID: 30652005, PS4_Moderate). At least one proband harboring this variant exhibits a phenotype including appearance of schisis and reduced visual acuity before age 13 years, which together are specific for X-linked retinoschisis (PMID: 33460243, PP4). This variant has been identified as a de novo occurrence with confirmed parental relationships in an individual meeting the PS2 requirement of some functional vision impairment in affected males by age 13 (1 point, PS2_Moderate, PMID: 33460243). The variant has been reported to segregate with retinal dystrophy through 1 meiosis in a family with two affected brothers (PP1; PMID: 30652005). The computational predictor REVEL gives a score of 0.974, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RS1 function (PP3_Strong). The computational splicing predictor SpliceAI gives a delta score of 0.00 for all predictive splice changes, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RS1 splicing. COS‐7 cells exogenously expressing the variant exhibit loss of RS1 secretion into the medium relative to the wild-type control (PMID: 16361673, PS3_Supporting). This variant is a missense substitution affecting a critical amino acid residue involved in disulfide bridge formation as defined by the ClinGen X-linked IRD VCEP (PMID: 26812435). However, the PP3_Strong code has been met, which is ineligible to be used in combination with the PM1 code at any strength, so the PM1 code was not met. In summary, this variant is classified as pathogenic for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: PM2_Supporting, PP3_Strong, PS3_Supporting, PP1, PP4, PS2_Moderate, and PS4_Moderate.
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects RS1 protein function (PMID: 16361673). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function. This variant has been observed in individual(s) with retinoschisis (PMID: 10533068, 30652005, Invitae). ClinVar contains an entry for this variant (Variation ID: 9893). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with arginine at codon 223 of the RS1 protein (p.Cys223Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at